nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP3A4—type 2 diabetes mellitus	0.138	1	CbGaD
Ifosfamide—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0577	0.0933	CbGbCtD
Ifosfamide—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0291	0.047	CbGbCtD
Ifosfamide—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0269	0.0435	CbGbCtD
Ifosfamide—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0269	0.0435	CbGbCtD
Ifosfamide—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0248	0.0401	CbGbCtD
Ifosfamide—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0215	0.0347	CbGbCtD
Ifosfamide—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0204	0.0329	CbGbCtD
Ifosfamide—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0195	0.0316	CbGbCtD
Ifosfamide—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0172	0.0277	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0163	0.0264	CbGbCtD
Ifosfamide—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0163	0.0264	CbGbCtD
Ifosfamide—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0155	0.0251	CbGbCtD
Ifosfamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0153	0.0248	CbGbCtD
Ifosfamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.015	0.0242	CbGbCtD
Ifosfamide—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0143	0.0232	CbGbCtD
Ifosfamide—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0138	0.0224	CbGbCtD
Ifosfamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0137	0.0221	CbGbCtD
Ifosfamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.013	0.021	CbGbCtD
Ifosfamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.013	0.021	CbGbCtD
Ifosfamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0127	0.0206	CbGbCtD
Ifosfamide—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0122	0.0198	CbGbCtD
Ifosfamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0194	CbGbCtD
Ifosfamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0116	0.0188	CbGbCtD
Ifosfamide—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0113	0.0182	CbGbCtD
Ifosfamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0108	0.0175	CbGbCtD
Ifosfamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0175	CbGbCtD
Ifosfamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00999	0.0161	CbGbCtD
Ifosfamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00977	0.0158	CbGbCtD
Ifosfamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00965	0.0156	CbGbCtD
Ifosfamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00883	0.0143	CbGbCtD
Ifosfamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00871	0.0141	CbGbCtD
Ifosfamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00821	0.0133	CbGbCtD
Ifosfamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00797	0.0129	CbGbCtD
Ifosfamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00787	0.0127	CbGbCtD
Ifosfamide—CYP3A5—Losartan—type 2 diabetes mellitus	0.00756	0.0122	CbGbCtD
Ifosfamide—CYP2C8—Losartan—type 2 diabetes mellitus	0.00727	0.0117	CbGbCtD
Ifosfamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00696	0.0113	CbGbCtD
Ifosfamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00667	0.0108	CbGbCtD
Ifosfamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0063	0.0102	CbGbCtD
Ifosfamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.0061	0.00985	CbGbCtD
Ifosfamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00554	0.00896	CbGbCtD
Ifosfamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00507	0.00819	CbGbCtD
Ifosfamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00477	0.00771	CbGbCtD
Ifosfamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00458	0.00739	CbGbCtD
Ifosfamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00458	0.00739	CbGbCtD
Ifosfamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00433	0.00699	CbGbCtD
Ifosfamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00322	0.00521	CbGbCtD
Ifosfamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00295	0.00476	CbGbCtD
Ifosfamide—Cyclophosphamide—CYP3A4—type 2 diabetes mellitus	0.000495	1	CrCbGaD
Ifosfamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.82e-05	0.000449	CcSEcCtD
Ifosfamide—Discomfort—Metformin—type 2 diabetes mellitus	7.81e-05	0.000448	CcSEcCtD
Ifosfamide—Fatigue—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000448	CcSEcCtD
Ifosfamide—Nausea—Glipizide—type 2 diabetes mellitus	7.78e-05	0.000447	CcSEcCtD
Ifosfamide—Vomiting—Glimepiride—type 2 diabetes mellitus	7.77e-05	0.000447	CcSEcCtD
Ifosfamide—Hypotension—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000447	CcSEcCtD
Ifosfamide—Vision blurred—Losartan—type 2 diabetes mellitus	7.77e-05	0.000446	CcSEcCtD
Ifosfamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.75e-05	0.000445	CcSEcCtD
Ifosfamide—Pain—Gliclazide—type 2 diabetes mellitus	7.74e-05	0.000445	CcSEcCtD
Ifosfamide—Constipation—Gliclazide—type 2 diabetes mellitus	7.74e-05	0.000445	CcSEcCtD
Ifosfamide—Rash—Glimepiride—type 2 diabetes mellitus	7.71e-05	0.000443	CcSEcCtD
Ifosfamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.7e-05	0.000442	CcSEcCtD
Ifosfamide—Rash—Sitagliptin—type 2 diabetes mellitus	7.68e-05	0.000441	CcSEcCtD
Ifosfamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.68e-05	0.000441	CcSEcCtD
Ifosfamide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000441	CcSEcCtD
Ifosfamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.65e-05	0.000439	CcSEcCtD
Ifosfamide—Cough—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000439	CcSEcCtD
Ifosfamide—Anaemia—Losartan—type 2 diabetes mellitus	7.62e-05	0.000438	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.58e-05	0.000435	CcSEcCtD
Ifosfamide—Agitation—Losartan—type 2 diabetes mellitus	7.57e-05	0.000435	CcSEcCtD
Ifosfamide—Oedema—Metformin—type 2 diabetes mellitus	7.57e-05	0.000435	CcSEcCtD
Ifosfamide—Tinnitus—Ramipril—type 2 diabetes mellitus	7.57e-05	0.000435	CcSEcCtD
Ifosfamide—Hypertension—Irbesartan—type 2 diabetes mellitus	7.56e-05	0.000434	CcSEcCtD
Ifosfamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.55e-05	0.000434	CcSEcCtD
Ifosfamide—Flushing—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000433	CcSEcCtD
Ifosfamide—Angioedema—Losartan—type 2 diabetes mellitus	7.53e-05	0.000433	CcSEcCtD
Ifosfamide—Infection—Metformin—type 2 diabetes mellitus	7.53e-05	0.000432	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.49e-05	0.00043	CcSEcCtD
Ifosfamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000429	CcSEcCtD
Ifosfamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.46e-05	0.000429	CcSEcCtD
Ifosfamide—Chest pain—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000428	CcSEcCtD
Ifosfamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000428	CcSEcCtD
Ifosfamide—Myalgia—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000428	CcSEcCtD
Ifosfamide—Malaise—Losartan—type 2 diabetes mellitus	7.43e-05	0.000427	CcSEcCtD
Ifosfamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.43e-05	0.000427	CcSEcCtD
Ifosfamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.43e-05	0.000427	CcSEcCtD
Ifosfamide—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.42e-05	0.000426	CcSEcCtD
Ifosfamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000426	CcSEcCtD
Ifosfamide—Vertigo—Losartan—type 2 diabetes mellitus	7.41e-05	0.000425	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000425	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.4e-05	0.000425	CcSEcCtD
Ifosfamide—Somnolence—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000425	CcSEcCtD
Ifosfamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000424	CcSEcCtD
Ifosfamide—Leukopenia—Losartan—type 2 diabetes mellitus	7.38e-05	0.000424	CcSEcCtD
Ifosfamide—Discomfort—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000423	CcSEcCtD
Ifosfamide—Skin disorder—Metformin—type 2 diabetes mellitus	7.36e-05	0.000423	CcSEcCtD
Ifosfamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000421	CcSEcCtD
Ifosfamide—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.32e-05	0.000421	CcSEcCtD
Ifosfamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.32e-05	0.00042	CcSEcCtD
Ifosfamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.29e-05	0.000419	CcSEcCtD
Ifosfamide—Palpitations—Losartan—type 2 diabetes mellitus	7.28e-05	0.000418	CcSEcCtD
Ifosfamide—Nausea—Glimepiride—type 2 diabetes mellitus	7.26e-05	0.000417	CcSEcCtD
Ifosfamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000417	CcSEcCtD
Ifosfamide—Nausea—Sitagliptin—type 2 diabetes mellitus	7.24e-05	0.000416	CcSEcCtD
Ifosfamide—Asthenia—Glyburide—type 2 diabetes mellitus	7.23e-05	0.000416	CcSEcCtD
Ifosfamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.23e-05	0.000415	CcSEcCtD
Ifosfamide—Anorexia—Metformin—type 2 diabetes mellitus	7.22e-05	0.000415	CcSEcCtD
Ifosfamide—Cough—Losartan—type 2 diabetes mellitus	7.19e-05	0.000413	CcSEcCtD
Ifosfamide—Urticaria—Gliclazide—type 2 diabetes mellitus	7.19e-05	0.000413	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000413	CcSEcCtD
Ifosfamide—Alopecia—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000412	CcSEcCtD
Ifosfamide—Fatigue—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000412	CcSEcCtD
Ifosfamide—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.16e-05	0.000411	CcSEcCtD
Ifosfamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.16e-05	0.000411	CcSEcCtD
Ifosfamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000411	CcSEcCtD
Ifosfamide—Oedema—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000411	CcSEcCtD
Ifosfamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.14e-05	0.00041	CcSEcCtD
Ifosfamide—Pruritus—Glyburide—type 2 diabetes mellitus	7.13e-05	0.00041	CcSEcCtD
Ifosfamide—Mental disorder—Ramipril—type 2 diabetes mellitus	7.11e-05	0.000409	CcSEcCtD
Ifosfamide—Constipation—Valsartan—type 2 diabetes mellitus	7.11e-05	0.000409	CcSEcCtD
Ifosfamide—Infection—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000408	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000408	CcSEcCtD
Ifosfamide—Fatigue—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000407	CcSEcCtD
Ifosfamide—Hypotension—Metformin—type 2 diabetes mellitus	7.08e-05	0.000407	CcSEcCtD
Ifosfamide—Malnutrition—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000406	CcSEcCtD
Ifosfamide—Erythema—Ramipril—type 2 diabetes mellitus	7.07e-05	0.000406	CcSEcCtD
Ifosfamide—Pain—Orlistat—type 2 diabetes mellitus	7.03e-05	0.000404	CcSEcCtD
Ifosfamide—Chest pain—Losartan—type 2 diabetes mellitus	7.02e-05	0.000403	CcSEcCtD
Ifosfamide—Arthralgia—Losartan—type 2 diabetes mellitus	7.02e-05	0.000403	CcSEcCtD
Ifosfamide—Myalgia—Losartan—type 2 diabetes mellitus	7.02e-05	0.000403	CcSEcCtD
Ifosfamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.01e-05	0.000403	CcSEcCtD
Ifosfamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000403	CcSEcCtD
Ifosfamide—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7e-05	0.000402	CcSEcCtD
Ifosfamide—Rash—Bromocriptine—type 2 diabetes mellitus	6.95e-05	0.0004	CcSEcCtD
Ifosfamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.95e-05	0.000399	CcSEcCtD
Ifosfamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000399	CcSEcCtD
Ifosfamide—Discomfort—Losartan—type 2 diabetes mellitus	6.93e-05	0.000398	CcSEcCtD
Ifosfamide—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000397	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.9e-05	0.000396	CcSEcCtD
Ifosfamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000396	CcSEcCtD
Ifosfamide—Anorexia—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000391	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.8e-05	0.000391	CcSEcCtD
Ifosfamide—Paraesthesia—Metformin—type 2 diabetes mellitus	6.8e-05	0.000391	CcSEcCtD
Ifosfamide—Confusional state—Losartan—type 2 diabetes mellitus	6.78e-05	0.00039	CcSEcCtD
Ifosfamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.77e-05	0.000389	CcSEcCtD
Ifosfamide—Dyspnoea—Metformin—type 2 diabetes mellitus	6.75e-05	0.000388	CcSEcCtD
Ifosfamide—Somnolence—Metformin—type 2 diabetes mellitus	6.73e-05	0.000387	CcSEcCtD
Ifosfamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.73e-05	0.000386	CcSEcCtD
Ifosfamide—Oedema—Losartan—type 2 diabetes mellitus	6.73e-05	0.000386	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.72e-05	0.000386	CcSEcCtD
Ifosfamide—Infection—Losartan—type 2 diabetes mellitus	6.68e-05	0.000384	CcSEcCtD
Ifosfamide—Hypotension—Irbesartan—type 2 diabetes mellitus	6.68e-05	0.000384	CcSEcCtD
Ifosfamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.67e-05	0.000383	CcSEcCtD
Ifosfamide—Urticaria—Valsartan—type 2 diabetes mellitus	6.61e-05	0.00038	CcSEcCtD
Ifosfamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.6e-05	0.000379	CcSEcCtD
Ifosfamide—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.59e-05	0.000378	CcSEcCtD
Ifosfamide—Decreased appetite—Metformin—type 2 diabetes mellitus	6.58e-05	0.000378	CcSEcCtD
Ifosfamide—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.58e-05	0.000378	CcSEcCtD
Ifosfamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000377	CcSEcCtD
Ifosfamide—Nausea—Bromocriptine—type 2 diabetes mellitus	6.55e-05	0.000376	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.54e-05	0.000376	CcSEcCtD
Ifosfamide—Fatigue—Metformin—type 2 diabetes mellitus	6.53e-05	0.000375	CcSEcCtD
Ifosfamide—Urticaria—Orlistat—type 2 diabetes mellitus	6.53e-05	0.000375	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.51e-05	0.000374	CcSEcCtD
Ifosfamide—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.5e-05	0.000374	CcSEcCtD
Ifosfamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.5e-05	0.000373	CcSEcCtD
Ifosfamide—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.5e-05	0.000373	CcSEcCtD
Ifosfamide—Asthenia—Gliclazide—type 2 diabetes mellitus	6.5e-05	0.000373	CcSEcCtD
Ifosfamide—Agitation—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000373	CcSEcCtD
Ifosfamide—Constipation—Metformin—type 2 diabetes mellitus	6.48e-05	0.000372	CcSEcCtD
Ifosfamide—Angioedema—Ramipril—type 2 diabetes mellitus	6.46e-05	0.000371	CcSEcCtD
Ifosfamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000369	CcSEcCtD
Ifosfamide—Anorexia—Losartan—type 2 diabetes mellitus	6.41e-05	0.000368	CcSEcCtD
Ifosfamide—Vomiting—Glyburide—type 2 diabetes mellitus	6.41e-05	0.000368	CcSEcCtD
Ifosfamide—Pruritus—Gliclazide—type 2 diabetes mellitus	6.41e-05	0.000368	CcSEcCtD
Ifosfamide—Malaise—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000366	CcSEcCtD
Ifosfamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000366	CcSEcCtD
Ifosfamide—Rash—Glyburide—type 2 diabetes mellitus	6.36e-05	0.000365	CcSEcCtD
Ifosfamide—Somnolence—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000365	CcSEcCtD
Ifosfamide—Dermatitis—Glyburide—type 2 diabetes mellitus	6.35e-05	0.000365	CcSEcCtD
Ifosfamide—Vertigo—Ramipril—type 2 diabetes mellitus	6.35e-05	0.000365	CcSEcCtD
Ifosfamide—Leukopenia—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000363	CcSEcCtD
Ifosfamide—Hypotension—Losartan—type 2 diabetes mellitus	6.29e-05	0.000361	CcSEcCtD
Ifosfamide—Palpitations—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000359	CcSEcCtD
Ifosfamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.24e-05	0.000359	CcSEcCtD
Ifosfamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000357	CcSEcCtD
Ifosfamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.19e-05	0.000356	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.19e-05	0.000356	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000355	CcSEcCtD
Ifosfamide—Cough—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000354	CcSEcCtD
Ifosfamide—Fatigue—Irbesartan—type 2 diabetes mellitus	6.16e-05	0.000354	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.13e-05	0.000352	CcSEcCtD
Ifosfamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.13e-05	0.000352	CcSEcCtD
Ifosfamide—Convulsion—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000352	CcSEcCtD
Ifosfamide—Constipation—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000351	CcSEcCtD
Ifosfamide—Pain—Irbesartan—type 2 diabetes mellitus	6.11e-05	0.000351	CcSEcCtD
Ifosfamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.06e-05	0.000348	CcSEcCtD
Ifosfamide—Paraesthesia—Losartan—type 2 diabetes mellitus	6.04e-05	0.000347	CcSEcCtD
Ifosfamide—Urticaria—Metformin—type 2 diabetes mellitus	6.02e-05	0.000346	CcSEcCtD
Ifosfamide—Chest pain—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000346	CcSEcCtD
Ifosfamide—Myalgia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000346	CcSEcCtD
Ifosfamide—Arthralgia—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000346	CcSEcCtD
Ifosfamide—Dyspnoea—Losartan—type 2 diabetes mellitus	6e-05	0.000345	CcSEcCtD
Ifosfamide—Nausea—Glyburide—type 2 diabetes mellitus	5.99e-05	0.000344	CcSEcCtD
Ifosfamide—Abdominal pain—Metformin—type 2 diabetes mellitus	5.99e-05	0.000344	CcSEcCtD
Ifosfamide—Dizziness—Gliclazide—type 2 diabetes mellitus	5.99e-05	0.000344	CcSEcCtD
Ifosfamide—Somnolence—Losartan—type 2 diabetes mellitus	5.98e-05	0.000344	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000343	CcSEcCtD
Ifosfamide—Asthenia—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000343	CcSEcCtD
Ifosfamide—Discomfort—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000342	CcSEcCtD
Ifosfamide—Asthenia—Orlistat—type 2 diabetes mellitus	5.9e-05	0.000339	CcSEcCtD
Ifosfamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.89e-05	0.000338	CcSEcCtD
Ifosfamide—Pruritus—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000338	CcSEcCtD
Ifosfamide—Decreased appetite—Losartan—type 2 diabetes mellitus	5.85e-05	0.000336	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000336	CcSEcCtD
Ifosfamide—Confusional state—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000334	CcSEcCtD
Ifosfamide—Pruritus—Orlistat—type 2 diabetes mellitus	5.82e-05	0.000334	CcSEcCtD
Ifosfamide—Fatigue—Losartan—type 2 diabetes mellitus	5.8e-05	0.000333	CcSEcCtD
Ifosfamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000331	CcSEcCtD
Ifosfamide—Oedema—Ramipril—type 2 diabetes mellitus	5.77e-05	0.000331	CcSEcCtD
Ifosfamide—Vomiting—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000331	CcSEcCtD
Ifosfamide—Pain—Losartan—type 2 diabetes mellitus	5.75e-05	0.00033	CcSEcCtD
Ifosfamide—Constipation—Losartan—type 2 diabetes mellitus	5.75e-05	0.00033	CcSEcCtD
Ifosfamide—Rash—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.000328	CcSEcCtD
Ifosfamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.7e-05	0.000328	CcSEcCtD
Ifosfamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000327	CcSEcCtD
Ifosfamide—Urticaria—Irbesartan—type 2 diabetes mellitus	5.68e-05	0.000326	CcSEcCtD
Ifosfamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000325	CcSEcCtD
Ifosfamide—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.65e-05	0.000325	CcSEcCtD
Ifosfamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.65e-05	0.000325	CcSEcCtD
Ifosfamide—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.65e-05	0.000324	CcSEcCtD
Ifosfamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000323	CcSEcCtD
Ifosfamide—Skin disorder—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000322	CcSEcCtD
Ifosfamide—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.58e-05	0.00032	CcSEcCtD
Ifosfamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.54e-05	0.000318	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.5e-05	0.000316	CcSEcCtD
Ifosfamide—Dizziness—Valsartan—type 2 diabetes mellitus	5.5e-05	0.000316	CcSEcCtD
Ifosfamide—Anorexia—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000316	CcSEcCtD
Ifosfamide—Dizziness—Orlistat—type 2 diabetes mellitus	5.44e-05	0.000312	CcSEcCtD
Ifosfamide—Asthenia—Metformin—type 2 diabetes mellitus	5.43e-05	0.000312	CcSEcCtD
Ifosfamide—Hypotension—Ramipril—type 2 diabetes mellitus	5.39e-05	0.00031	CcSEcCtD
Ifosfamide—Nausea—Gliclazide—type 2 diabetes mellitus	5.38e-05	0.000309	CcSEcCtD
Ifosfamide—Pruritus—Metformin—type 2 diabetes mellitus	5.36e-05	0.000308	CcSEcCtD
Ifosfamide—Urticaria—Losartan—type 2 diabetes mellitus	5.34e-05	0.000307	CcSEcCtD
Ifosfamide—Body temperature increased—Losartan—type 2 diabetes mellitus	5.32e-05	0.000306	CcSEcCtD
Ifosfamide—Abdominal pain—Losartan—type 2 diabetes mellitus	5.32e-05	0.000306	CcSEcCtD
Ifosfamide—Vomiting—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000304	CcSEcCtD
Ifosfamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000303	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000302	CcSEcCtD
Ifosfamide—Rash—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000301	CcSEcCtD
Ifosfamide—Dermatitis—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000301	CcSEcCtD
Ifosfamide—Vomiting—Orlistat—type 2 diabetes mellitus	5.23e-05	0.0003	CcSEcCtD
Ifosfamide—Diarrhoea—Metformin—type 2 diabetes mellitus	5.18e-05	0.000298	CcSEcCtD
Ifosfamide—Rash—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000298	CcSEcCtD
Ifosfamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000298	CcSEcCtD
Ifosfamide—Dermatitis—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000297	CcSEcCtD
Ifosfamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000295	CcSEcCtD
Ifosfamide—Asthenia—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000295	CcSEcCtD
Ifosfamide—Somnolence—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000295	CcSEcCtD
Ifosfamide—Pruritus—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000291	CcSEcCtD
Ifosfamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000288	CcSEcCtD
Ifosfamide—Dizziness—Metformin—type 2 diabetes mellitus	5.01e-05	0.000288	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000286	CcSEcCtD
Ifosfamide—Fatigue—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000286	CcSEcCtD
Ifosfamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.96e-05	0.000285	CcSEcCtD
Ifosfamide—Nausea—Valsartan—type 2 diabetes mellitus	4.94e-05	0.000284	CcSEcCtD
Ifosfamide—Constipation—Ramipril—type 2 diabetes mellitus	4.93e-05	0.000283	CcSEcCtD
Ifosfamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000281	CcSEcCtD
Ifosfamide—Nausea—Orlistat—type 2 diabetes mellitus	4.88e-05	0.00028	CcSEcCtD
Ifosfamide—Asthenia—Losartan—type 2 diabetes mellitus	4.83e-05	0.000277	CcSEcCtD
Ifosfamide—Vomiting—Metformin—type 2 diabetes mellitus	4.82e-05	0.000277	CcSEcCtD
Ifosfamide—Rash—Metformin—type 2 diabetes mellitus	4.78e-05	0.000274	CcSEcCtD
Ifosfamide—Dermatitis—Metformin—type 2 diabetes mellitus	4.77e-05	0.000274	CcSEcCtD
Ifosfamide—Pruritus—Losartan—type 2 diabetes mellitus	4.76e-05	0.000273	CcSEcCtD
Ifosfamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.75e-05	0.000273	CcSEcCtD
Ifosfamide—Dizziness—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000272	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000271	CcSEcCtD
Ifosfamide—Diarrhoea—Losartan—type 2 diabetes mellitus	4.6e-05	0.000264	CcSEcCtD
Ifosfamide—Urticaria—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000263	CcSEcCtD
Ifosfamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000262	CcSEcCtD
Ifosfamide—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000262	CcSEcCtD
Ifosfamide—Vomiting—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000261	CcSEcCtD
Ifosfamide—Rash—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000259	CcSEcCtD
Ifosfamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000259	CcSEcCtD
Ifosfamide—Nausea—Metformin—type 2 diabetes mellitus	4.5e-05	0.000258	CcSEcCtD
Ifosfamide—Dizziness—Losartan—type 2 diabetes mellitus	4.45e-05	0.000256	CcSEcCtD
Ifosfamide—Vomiting—Losartan—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Ifosfamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.25e-05	0.000244	CcSEcCtD
Ifosfamide—Nausea—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000244	CcSEcCtD
Ifosfamide—Rash—Losartan—type 2 diabetes mellitus	4.24e-05	0.000244	CcSEcCtD
Ifosfamide—Dermatitis—Losartan—type 2 diabetes mellitus	4.24e-05	0.000243	CcSEcCtD
Ifosfamide—Asthenia—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000238	CcSEcCtD
Ifosfamide—Pruritus—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000234	CcSEcCtD
Ifosfamide—Nausea—Losartan—type 2 diabetes mellitus	4e-05	0.00023	CcSEcCtD
Ifosfamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000227	CcSEcCtD
Ifosfamide—Dizziness—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000219	CcSEcCtD
Ifosfamide—Vomiting—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000211	CcSEcCtD
Ifosfamide—Rash—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000209	CcSEcCtD
Ifosfamide—Dermatitis—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000209	CcSEcCtD
Ifosfamide—Nausea—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000197	CcSEcCtD
Ifosfamide—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	2.32e-05	0.0741	CbGeAlD
Ifosfamide—PTGS1—artery—type 2 diabetes mellitus	2.23e-05	0.0712	CbGeAlD
Ifosfamide—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	1.99e-05	0.0634	CbGeAlD
Ifosfamide—PTGS1—endothelium—type 2 diabetes mellitus	1.89e-05	0.0601	CbGeAlD
Ifosfamide—CYP2C18—liver—type 2 diabetes mellitus	1.6e-05	0.0509	CbGeAlD
Ifosfamide—CYP3A7—liver—type 2 diabetes mellitus	1.52e-05	0.0484	CbGeAlD
Ifosfamide—CYP2A6—adipose tissue—type 2 diabetes mellitus	1.5e-05	0.0479	CbGeAlD
Ifosfamide—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	1.29e-05	0.0411	CbGeAlD
Ifosfamide—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	1.19e-05	0.0381	CbGeAlD
Ifosfamide—CYP2A6—liver—type 2 diabetes mellitus	1.05e-05	0.0336	CbGeAlD
Ifosfamide—CYP3A5—nephron tubule—type 2 diabetes mellitus	9.62e-06	0.0307	CbGeAlD
Ifosfamide—CYP2B6—nephron tubule—type 2 diabetes mellitus	9.56e-06	0.0305	CbGeAlD
Ifosfamide—CYP2C8—kidney—type 2 diabetes mellitus	9.36e-06	0.0298	CbGeAlD
Ifosfamide—CYP2B6—cardiovascular system—type 2 diabetes mellitus	8.58e-06	0.0274	CbGeAlD
Ifosfamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	8.5e-06	0.0271	CbGeAlD
Ifosfamide—CYP3A5—kidney—type 2 diabetes mellitus	8.45e-06	0.0269	CbGeAlD
Ifosfamide—CYP2B6—kidney—type 2 diabetes mellitus	8.4e-06	0.0268	CbGeAlD
Ifosfamide—CYP3A5—pancreas—type 2 diabetes mellitus	8.4e-06	0.0268	CbGeAlD
Ifosfamide—CYP3A5—cortex of kidney—type 2 diabetes mellitus	8.23e-06	0.0262	CbGeAlD
Ifosfamide—PTGS1—cardiovascular system—type 2 diabetes mellitus	7.76e-06	0.0247	CbGeAlD
Ifosfamide—CYP3A5—adipose tissue—type 2 diabetes mellitus	7.62e-06	0.0243	CbGeAlD
Ifosfamide—PTGS1—kidney—type 2 diabetes mellitus	7.59e-06	0.0242	CbGeAlD
Ifosfamide—PTGS1—adipose tissue—type 2 diabetes mellitus	6.84e-06	0.0218	CbGeAlD
Ifosfamide—CYP2C19—liver—type 2 diabetes mellitus	6.78e-06	0.0216	CbGeAlD
Ifosfamide—CYP3A4—kidney—type 2 diabetes mellitus	6.34e-06	0.0202	CbGeAlD
Ifosfamide—CYP2C8—liver—type 2 diabetes mellitus	5.92e-06	0.0189	CbGeAlD
Ifosfamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.69e-06	8.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.67e-06	8.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.67e-06	8.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.65e-06	8.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.65e-06	8.25e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	5.65e-06	8.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.64e-06	8.24e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—MTHFR—type 2 diabetes mellitus	5.62e-06	8.21e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.61e-06	8.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.59e-06	8.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.59e-06	8.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.59e-06	8.17e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	5.55e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.55e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.55e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.55e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.55e-06	8.11e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	5.53e-06	8.08e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	5.53e-06	8.08e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.53e-06	8.08e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.53e-06	8.07e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARA—type 2 diabetes mellitus	5.51e-06	8.05e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	5.51e-06	8.04e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.5e-06	8.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	5.49e-06	8.02e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.49e-06	8.01e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	5.47e-06	7.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.44e-06	7.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	5.43e-06	7.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	5.43e-06	7.94e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	5.43e-06	7.93e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.41e-06	7.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.41e-06	7.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.38e-06	7.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.37e-06	7.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—liver—type 2 diabetes mellitus	5.34e-06	0.017	CbGeAlD
Ifosfamide—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	5.34e-06	7.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	5.32e-06	7.78e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.31e-06	7.76e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—liver—type 2 diabetes mellitus	5.31e-06	0.0169	CbGeAlD
Ifosfamide—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	5.27e-06	7.7e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—liver—type 2 diabetes mellitus	5.26e-06	0.0168	CbGeAlD
Ifosfamide—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	5.25e-06	7.67e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	5.23e-06	7.64e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.22e-06	7.62e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	5.17e-06	7.55e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.16e-06	7.53e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	5.13e-06	7.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.12e-06	7.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.12e-06	7.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.1e-06	7.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.1e-06	7.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.1e-06	7.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.06e-06	7.39e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.06e-06	7.39e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.04e-06	7.36e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.01e-06	7.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.01e-06	7.31e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.97e-06	7.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.96e-06	7.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.93e-06	7.2e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	4.93e-06	7.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.92e-06	7.19e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	4.91e-06	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.91e-06	7.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.89e-06	7.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.89e-06	7.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.88e-06	7.12e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.86e-06	7.09e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.85e-06	7.08e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.85e-06	7.08e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	4.82e-06	7.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.82e-06	7.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.8e-06	7.01e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	4.78e-06	6.99e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—INS—type 2 diabetes mellitus	4.73e-06	6.9e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.73e-06	6.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.72e-06	6.89e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.72e-06	6.89e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.72e-06	6.89e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.72e-06	6.89e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.68e-06	6.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.68e-06	6.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.68e-06	6.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.66e-06	6.81e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.66e-06	6.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.62e-06	6.75e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.61e-06	6.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.61e-06	6.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.6e-06	6.72e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	4.56e-06	6.66e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.53e-06	6.62e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.53e-06	6.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.5e-06	6.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.48e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.47e-06	6.53e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	4.47e-06	6.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.47e-06	6.52e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.45e-06	6.5e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.43e-06	6.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.42e-06	6.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.42e-06	6.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.35e-06	6.35e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.34e-06	6.34e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.33e-06	6.33e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.31e-06	6.29e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.28e-06	6.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.28e-06	6.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.26e-06	6.23e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.24e-06	6.19e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.22e-06	6.17e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.21e-06	6.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.21e-06	6.14e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.18e-06	6.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.18e-06	6.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.17e-06	6.1e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.17e-06	6.09e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.16e-06	6.08e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.16e-06	6.08e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.14e-06	6.05e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.14e-06	6.05e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.14e-06	6.05e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.13e-06	6.03e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.11e-06	6e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	4.1e-06	5.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.08e-06	5.96e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.05e-06	5.92e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—liver—type 2 diabetes mellitus	4.01e-06	0.0128	CbGeAlD
Ifosfamide—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4e-06	5.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.99e-06	5.82e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.93e-06	5.74e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.92e-06	5.72e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.92e-06	5.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.91e-06	5.71e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.88e-06	5.66e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.85e-06	5.62e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.85e-06	5.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.84e-06	5.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.81e-06	5.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.81e-06	5.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.81e-06	5.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.79e-06	5.54e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	3.79e-06	5.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.77e-06	5.51e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.77e-06	5.5e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.75e-06	5.48e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.75e-06	5.48e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.75e-06	5.48e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.74e-06	5.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.73e-06	5.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.73e-06	5.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.71e-06	5.42e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.68e-06	5.37e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.66e-06	5.35e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.65e-06	5.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.63e-06	5.31e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.62e-06	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.62e-06	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.61e-06	5.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.59e-06	5.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.59e-06	5.24e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	3.58e-06	5.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.57e-06	5.22e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.57e-06	5.21e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.54e-06	5.16e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.53e-06	5.16e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.52e-06	5.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.47e-06	5.07e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.43e-06	5e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.4e-06	4.96e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.39e-06	4.94e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.36e-06	4.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.36e-06	4.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.36e-06	4.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.36e-06	4.91e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.31e-06	4.83e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.3e-06	4.82e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.3e-06	4.82e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.27e-06	4.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.26e-06	4.75e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.26e-06	4.75e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.23e-06	4.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.2e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.2e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.19e-06	4.66e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.16e-06	4.62e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.16e-06	4.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.15e-06	4.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	4.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.11e-06	4.55e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.09e-06	4.51e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.09e-06	4.51e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.08e-06	4.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.07e-06	4.48e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	4.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.04e-06	4.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.04e-06	4.44e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.97e-06	4.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	2.96e-06	4.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.92e-06	4.26e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.92e-06	4.26e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.92e-06	4.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.91e-06	4.25e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.89e-06	4.22e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.88e-06	4.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.83e-06	4.13e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.8e-06	4.09e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.78e-06	4.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.73e-06	3.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.68e-06	3.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.68e-06	3.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	3.7e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.51e-06	3.67e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.51e-06	3.67e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.5e-06	3.65e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.5e-06	3.65e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	3.63e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.47e-06	3.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.45e-06	3.58e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.4e-06	3.5e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	3.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	3.49e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.33e-06	3.41e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.29e-06	3.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.28e-06	3.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.24e-06	3.27e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.23e-06	3.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.19e-06	3.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.18e-06	3.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.18e-06	3.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.17e-06	3.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.15e-06	3.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	3.01e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.02e-06	2.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	2.91e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.97e-06	2.87e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	2.86e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.92e-06	2.81e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	2.8e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-06	2.78e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	2.77e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.8e-06	2.63e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	2.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	2.39e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	2.19e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-06	2.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	2.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	2.1e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	2.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.31e-06	1.92e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.6e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1e-06	1.46e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.61e-07	9.65e-06	CbGpPWpGaD
